EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn's Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies


Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn's Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies



Dermatology and Therapy 6(4): 689-695



ISSN/ISBN: 2193-8210

PMID: 27844446

DOI: 10.1007/s13555-016-0156-z

Scalp psoriasis with alopecia is a rare cutaneous reaction to tumor necrosis factor alpha antagonists. This reaction often reverses with discontinuation of the offending drug and initiation of topical treatments; however, irreversible hair loss may occur if a scarring alopecia develops. We describe a woman with Crohn's disease who developed scalp psoriasis and alopecia secondary to infliximab. She had a remarkable recovery after discontinuation of infliximab and treatment with oral minocycline and topical therapy: mineral oil under occlusion, betamethasone lotion, and sequential coal tar, salicylic acid, and ketoconazole shampoos each day. The patient's alopecia completely resolved within 4 months of initiating this treatment regimen. In summary, early diagnosis of alopecia secondary to tumor necrosis factor alpha antagonist therapy is crucial in preventing diffuse alopecia and scalp psoriasis. In addition to discontinuing the offending agent, initiating aggressive adjuvant treatment with an oral antibiotic, topical therapies, or both, should be considered to reverse tumor necrosis factor alpha antagonist-induced alopecia and/or scalp psoriasis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058837625

Download citation: RISBibTeXText

Related references

Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab. European Review for Medical and Pharmacological Sciences 17(20): 2831-2836, 2013

Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab. References 33(4): E13791, 2020

Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab. Gastroenterologie Clinique et Biologique 34(2): 140-141, 2010

Psoriasis secundaria al tratamiento con infliximab y adalimumab en la enfermedad de Crohn - Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease. Anales de Pediatria (2003. Ed. Impresa) 70(3): 278-281, 2009

Development of diffuse alopecia with psoriasis-like eruptions during administration of infliximab for Crohn's disease. Inflammatory Bowel Diseases 19(3): E33-E34, 2013

A case of psoriasis induced by infliximab treatment for Crohn's disease. Korean Journal of Gastroenterology 56(5): 324-328, 2010

Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. Gastroenterology 144(5): S-22, 2013

Adalimumab-induced scalp psoriasis with severe alopecia. References 32(5): E13033, 2019

Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept. Dermatologic Therapy 27(4): 211-214, 2014

Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: case report and review of 142 cases. Journal of Drugs in Dermatology: Jdd 12(8): 939-943, 2013

Infliximab (Remicade°) : Maladie de Crohn Sévère chez les Enfants de Nombreuses Inconnues - Infliximab for Severe Child Crohn's Disease : A Critical Study. la Revue Prescrire 28(291): 11-11, 2008

A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies. Journal of drugs in dermatology: JDD 13(7): 848-853, 2014

Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease. Inflammatory Bowel Diseases 20(2): 251-258, 2014

Infliximab-induced psoriasis during therapy for Crohn's disease. Journal of Crohn's and Colitis 6(5): 610-616, 2012

Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients. Inflammatory Intestinal Diseases 2(3): 171-179, 2018